Seray Saray
Balikesir, 10100, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.
Journal: Journal of clinical medicine
Published: March 01, 2026
Stage 4A Lung Adenocarcinoma with Rare EGFR Exon 21 L861Q and Exon 18 G719A Co-Mutations Showing Complete PET-CT Response to Osimertinib: A Case Report.
Journal: Case reports in oncology
Published: December 17, 2025
Radiotherapy improves outcomes in patients with NSCLC receiving nivolumab.
Journal: BMC cancer
Published: September 23, 2025
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: Journal of clinical medicine
Published: July 02, 2025
Androgen Receptor: Clinical Importance in Breast Cancer Patients Receiving CDK 4/6 Inhibitor Treatment.
Journal: Medicina (Kaunas, Lithuania)
Published: June 27, 2025
Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?
Journal: Revista da Associacao Medica Brasileira (1992)
Published: April 26, 2025
Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study.
Journal: Anti-cancer drugs
Published: March 31, 2025
Predictive Factors for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing 177Lu-PSMA-617 Radioligand Treatment.
Journal: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Published: February 01, 2025
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study.
Journal: Therapeutic advances in medical oncology
Published: December 10, 2024
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study.
Journal: Scientific reports
Published: October 07, 2024
Case report: Drug-induced vitiligo during treatment with BRAF/MEK inhibitors in a patient with metastatic conjunctival melanoma.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 27, 2023
Last Updated: 09/26/2026